Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Brompheniramine maleate |
Is a |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
Brompheniramine measurement |
Component |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Brompheniramine adverse reaction |
Causative agent |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Allergy to brompheniramine |
Causative agent |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat 2 mg/5 ml eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat 10 mg/1 ml injektionsvæske, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + codeinphosphat + phenylpropanolaminhydrochlorid 2 mg/5 ml 10 mg/5 ml 12,5 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + dextromethorphanhydrobromid + phenylpropanolaminhydrochlorid 2 mg/5 ml 10 mg/5 ml 12,5 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 2 mg/5 ml 10 mg/5 ml 30 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml 15 mg/5 ml 60 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat 10 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
Brompheniramine maleate 6 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid 4 mg/5 ml 15 mg/5 ml 45 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat 4 mg/5 ml + dextromethorphanhydrobromid 30 mg/5 ml + pseudoephedrinhydrochlorid 60 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
Product containing brompheniramine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
brompheniraminmaleat 2 mg + dextromethorphanhydrobromid 10 mg + phenylpropanolaminhydrochlorid 12,5 mg væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat 2 mg + guaifenesin 200 mg + hydrocodonhydrogentartrat 5 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat 2 mg + hydrocodonhydrogentartrat 1,7 mg + pseudoephedrinhydrochlorid 30 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + dextromethorphanhydrobromid + pseudoephedrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + hydrocodonhydrogentartrat + pseudoephedrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
Brompheniramine maleate + pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + pseudoephedrinhydrochlorid 16 mg/240 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
brompheniraminmaleat + pseudoephedrinhydrochlorid 16 mg/240 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
Product containing brompheniramine and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Allergy to brompheniramine |
Causative agent |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
Brompheniramine maleate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
|
Product containing precisely brompheniramine 12 milligram and pseudoephedrine hydrochloride 120 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Brompheniramine- and pseudoephedrine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Brompheniramine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Product containing brompheniramine and guaifenesin and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
Product containing brompheniramine and guaifenesin and hydrocodone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
Brompheniramine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Product containing only brompheniramine and guaifenesin and hydrocodone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
Brompheniramine and pseudoephedrine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Brompheniramine and guaifenesin and hydrocodone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
Brompheniramine and pseudoephedrine only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Product containing only brompheniramine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Brompheniramine 800 microgram/mL and dextromethorphan 3 mg/mL and pseudoephedrine 12 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Brompheniramine 800 microgram/mL and dextromethorphan 6 mg/mL and pseudoephedrine 12 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Brompheniramine and codeine and phenylpropanolamine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Product containing only brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Brompheniramine- and codeine- and phenylpropanolamine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Product containing brompheniramine and codeine and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Brompheniramine- and dextromethorphan- and phenylpropanolamine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Brompheniramine- and dextromethorphan- and pseudoephedrine-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Product containing only brompheniramine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Product containing only brompheniramine and dextromethorphan and phenylpropanolamine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Product containing only brompheniramine and dextromethorphan and pseudoephedrine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Product containing only brompheniramine and dextromethorphan and pseudoephedrine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Brompheniramine- and dextromethorphan- and pseudoephedrine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Product containing brompheniramine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Product containing brompheniramine and dextromethorphan and phenylpropanolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Product containing only brompheniramine and codeine and phenylpropanolamine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely brompheniramine 6 milligram and pseudoephedrine hydrochloride 60 milligram/1 each conventional release oral capsule (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
Brompheniramine- and caffeine- and paracetamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
Brompheniramine and caffeine and paracetamol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
Product containing only brompheniramine and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |
Product containing brompheniramine and caffeine and paracetamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Brompheniramine (substance) |
Inferred relationship |
Some |
2 |